Press "Enter" to skip to content

Exclusive Report on Rubella Diagnostic Testing Market 2019 | Industry Drivers, Business Plans, Types, Applications, Challenges, Opportunities and Latest Trends Forecast to 2024

Rubella

The “Rubella Diagnostic Testing Market” research report 2019 delivers comprehensive information about the market ranging from the establishment to the predictable growth trend. Rubella Diagnostic Testing market report provides brief analytical data of the market contenders globally using advanced methodological approaches, such as SWOT analysis, production chain, cost, sales margin, financial details, recent developments. Rubella Diagnostic Testing market report also offers market competitors that includes detailed company profiles along with company product specifications.

Market Overview:

  • The major factors for the growth of the rubella diagnostic testing market include the government initiatives to curb the rubella virus, increasing incidences of rubella, and the introduction of advanced point-of-care diagnostic technologies, which are expected to boost the overall growth of the market over the forecast period.
  • There has been an increase in the number of incidences of rubella across the world. Rubella is an acute, contagious viral infection that causes a mild fever and rash illness in children and adults. Infection during pregnancy, especially during the first trimester, can result in miscarriage, stillbirth, fetal death, or infants with congenital malformations. According to the data published by the Centers for Disease Control and Prevention (CDC), rubella is a global health concern, and every year, more than 100,000 cases of congenital rubella syndrome (CRS) are reported, globally. A woman infected with rubella during the first three months of pregnancy has up to a 90% chance of giving birth to a baby with congenital rubella syndrome.
  • In 2015, the WHO Region of the Americas became the first in the world to be declared free of endemic transmission of rubella. Rubella can be prevented with the measles, mumps, and rubella (MMR) vaccine. Governments in various countries across the world are conducting vaccination programs to curb the incidences of rubella. As per the estimates of WHO, as of December 2016, 152 out of 194 countries had introduced rubella vaccines and reported rubella cases declined by 97%, from 670,894 cases in 102 countries, in 2000, to 22,361 cases in 165 countries in 2016.
  • On the other hand, as per the Global Vaccine Action Plan (GVAP) Assessment report, rubella control is lagging, with 42 countries yet to introduce the vaccine.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14244600

    In Rubella Diagnostic Testing Market Report, Following Companies Are Covered:

  • Abbott
  • Beckman Coulter Inc.
  • Bio Rad Laboratories Inc.
  • Biokit SA
  • bioMérieux SA
  • F. Hoffmann
  • La Roche Ltd
  • Ortho Clinical Diagnostics
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific
  • ZEUS Scientific Inc.

    Rubella Diagnostic Testing Market 2019 report will help the industry aspirants in arranging their strategies. The measurements offered in this report will be an exact and helpful manual to shape the business development. Additionally, will Provide historical data along with a future forecast and detailed analysis and also expected opportunities.

    Scope of the Report:

  • As per the , rubella diagnostic testing refers to the detection of the rubella virus. These tests are prescribed for pregnant women and may also be performed on babies born with congenital defects. Rubella can be detected with the help of various diagnostic tests, such as latex agglutination, enzyme immunoassay, radioimmunoassay (RIA), and fluorescent immunoassay (FIA), among others.

    Reasons for Buying Rubella Diagnostic Testing Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14244600

    Key Market Trends:

    Enzyme Immunoassay Segment under Testing Technique Accounted for the Largest Share in the Global Market

    The detection of rubella-specific immunoglobulin M (IgM) in serum is the standard test for the rapid laboratory diagnosis of rubella. IgM testing is the most commonly performed testing technique using commercial enzyme immunoassay (EIA) kits. The blood test detects antibodies that are made by the immune system to kill the rubella virus, and these antibodies remain in the bloodstream for years. The segment is expected to account for the largest market share, owing to the rising incidences of rubella.

    Asia-Pacific Accounted for the Highest Growth Rate in the Global Market

    The Asia-Pacific segment, by geography, was found to register the fastest growth rate for the rubella diagnostic testing market and is expected to show a similar trend over the forecast period, without significant fluctuations. The Asia-Pacific region holds the highest market share, owing to the presence of larger untapped opportunities, a lack of awareness in some countries, and government initiatives to curb the disease incidence. As per the Global Vaccine Action Plan (GVAP) Assessment report 2017, 42 countries have not yet introduced the vaccine, and two regions, Africa and the Eastern Mediterranean, have not yet set rubella elimination or control targets. Such regions are expected to face high incidences of rubella, which may further drive the growth of the market.

    The Research Document Will Answer Following Questions Such as:

    • What are the cutting-edge technologies responsible for driving the growth of the market?
    • What are the main applications of the market? What are the growth prospects to the market applications into the market?
    • At what stage of development are the key market products?
    • What are the shortcomings that has to face to become commercially viable? Is their growth and commercialization dependent on cost declines or technological/application breakthroughs?
    • What is the outlook for the industry?
    • What difference does performance characteristics of Rubella Diagnostic Testing create from those of established entities?

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14244600

    Detailed TOC of Rubella Diagnostic Testing Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Government Initiatives to Curb Rubella Virus
    4.2.2 Increasing Incidences of Rubella
    4.2.3 Introduction of Advance Point-of-care Diagnostic Technologies
    4.3 Market Restraints
    4.3.1 Lack of Awareness among Developing Regions
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Testing Technique
    5.1.1 Latex Agglutination
    5.1.2 Enzyme Immunoassay (EIA)
    5.1.3 Radioimmunoassay (RIA)
    5.1.4 Fluorescent Immunoassay (FIA)
    5.1.5 Other Testing Techniques
    5.2 Application
    5.2.1 Hospitals
    5.2.2 Laboratories
    5.2.3 Other Applications
    5.3 Geography
    5.3.1 North America
    5.3.1.1 US
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 UK
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East & Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East & Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Abbott
    6.1.2 Beckman Coulter Inc.
    6.1.3 Bio Rad Laboratories Inc.
    6.1.4 Biokit SA
    6.1.5 bioMérieux SA
    6.1.6 F. Hoffmann-La Roche Ltd
    6.1.7 Ortho Clinical Diagnostics
    6.1.8 Siemens Healthcare GmbH
    6.1.9 Thermo Fisher Scientific
    6.1.10 ZEUS Scientific Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    DevOps Tool Market Share, Size 2019 – Global Industry Future Demand, Global Research, Top Leading Players, Emerging Trends, Region by Forecast to 2026

    Bagged Food Market 2019 Industry Size, Trends, Global Growth, Recent Developments and Latest Technology, Forecast Research Report 2023

    Disposable Slippers Market 2019 Size, Share, Global Growth Factors, Future Trends, Opportunities, and Regional Outlook Forecast to 2023

    Green Tea Extract Market 2018 Global Industry Trends, Share, Size, Demand, Growth Opportunities, Industry Revenue, Future and Business Analysis by Forecast – 2023

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *